These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23946723)

  • 1. Preclinical cardiorenal interrelationships in essential hypertension.
    Tsioufis C; Tsiachris D; Kasiakogias A; Dimitriadis K; Petras D; Goumenos D; Siamopoulos K; Stefanadis C
    Cardiorenal Med; 2013 Apr; 3(1):38-47. PubMed ID: 23946723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective Effects of the Novel Compound Vastiras in a Preclinical Model of End-Organ Damage.
    Altara R; da Silva GJJ; Frisk M; Spelta F; Zouein FA; Louch WE; Booz GW; Cataliotti A
    Hypertension; 2020 May; 75(5):1195-1204. PubMed ID: 32200677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular hyperfiltration in essential hypertension: hormonal aspects.
    Regolisti G; Buzio C; Cavatorta A; De Martin L; Cavalli R; Perazzoli F; Coghi P; Cabassi A; Pucci F; Borghetti A
    Acta Biomed Ateneo Parmense; 1992; 63(1-2):163-73. PubMed ID: 1340661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy.
    Hayakawa H; Coffee K; Raij L
    Circulation; 1997 Oct; 96(7):2407-13. PubMed ID: 9337217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension and Organ Damage in Women.
    Muiesan ML; Paini A; Aggiusti C; Bertacchini F; Rosei CA; Salvetti M
    High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):245-252. PubMed ID: 29943358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAAS inhibition and cardiorenal syndrome.
    Onuigbo MA
    Curr Hypertens Rev; 2014; 10(2):107-11. PubMed ID: 25549841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Organ damage and cardiorenal syndrome in acute heart failure].
    Casado Cerrada J; Pérez Calvo JI
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():26-31. PubMed ID: 24930080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension.
    Shigematsu Y; Hamada M; Mukai M; Matsuoka H; Sumimoto T; Hiwada K
    J Hypertens; 1995 Jan; 13(1):155-60. PubMed ID: 7759846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies.
    Fu Q; Cao L; Li H; Wang B; Li Z
    Chin Med J (Engl); 2014; 127(16):3011-8. PubMed ID: 25131243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiorenal Syndrome Revisited.
    Zannad F; Rossignol P
    Circulation; 2018 Aug; 138(9):929-944. PubMed ID: 30354446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients.
    Henskens LH; van Oostenbrugge RJ; Kroon AA; Hofman PA; Lodder J; de Leeuw PW
    J Hypertens; 2009 Apr; 27(4):846-53. PubMed ID: 19300113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney Response to Heart Failure: Proteomic Analysis of Cardiorenal Syndrome.
    Melenovsky V; Cervenka L; Viklicky O; Franekova J; Havlenova T; Behounek M; Chmel M; Petrak J
    Kidney Blood Press Res; 2018; 43(5):1437-1450. PubMed ID: 30235455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary hemodynamics in hypertensive heart disease. Basic concepts, clinical consequences, and experimental analysis of regression of hypertensive microangiopathy.
    Strauer BE
    Am J Med; 1988 Mar; 84(3A):45-54. PubMed ID: 2975465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular hyperfiltration indicates early target organ damage in essential hypertension.
    Schmieder RE; Messerli FH; Garavaglia G; Nunez B
    JAMA; 1990 Dec; 264(21):2775-80. PubMed ID: 2146412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension.
    Leoncini G; Viazzi F; Parodi D; Vettoretti S; Ratto E; Ravera M; Tomolillo C; Del Sette M; Bezante GP; Deferrari G; Pontremoli R
    Hypertension; 2003 Jul; 42(1):14-8. PubMed ID: 12756221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular dilatation and subclinical renal damage in primary hypertension.
    Ratto E; Viazzi F; Bonino B; Gonnella A; Garneri D; Parodi EL; Bezante GP; Derchi LE; Leoncini G; Pontremoli R
    J Hypertens; 2015 Mar; 33(3):605-11; discussion 611. PubMed ID: 25426568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target organ cross talk in cardiorenal syndrome: animal models.
    Bongartz LG; Braam B; Gaillard CA; Cramer MJ; Goldschmeding R; Verhaar MC; Doevendans PA; Joles JA
    Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1253-63. PubMed ID: 22914779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states.
    Brewster UC; Setaro JF; Perazella MA
    Am J Med Sci; 2003 Jul; 326(1):15-24. PubMed ID: 12861121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension.
    Cerasola G; Cottone S; Mulé G; Nardi E; Mangano MT; Andronico G; Contorno A; Li Vecchi M; Galione P; Renda F; Piazza G; Volpe V; Lisi A; Ferrara L; Panepinto N; Riccobene R
    J Hypertens; 1996 Jul; 14(7):915-20. PubMed ID: 8818932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.